Staphylococcus aureus bacteremia in patients with hematologic malignancies: A retrospective case-control study

Haematologica

Volumn 88, Issue 8, 2003, Pages 923-930

  Venditri, Mario ^a   Falcone, Marco ^a   Micozzi, Alessandra ^a   Carfagna, Paolo ^a   Taglietti, Fabrizio ^a   Serra, Pietro F ^a   Martino, Pietro ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Hematologic malignancies; Inflammatory response; Staphylococcus aureus bacteremia

Indexed keywords

ABSCESS; ADOLESCENT; ADULT; AGED; ARTICLE; BACTEREMIA; CASE CONTROL STUDY; CLINICAL FEATURE; CONTROLLED STUDY; DATA ANALYSIS; ENDOCARDITIS; FEMALE; GRAM NEGATIVE SEPSIS; HEMATOLOGIC MALIGNANCY; HOSPITAL INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORBIDITY; MORTALITY; NEUTROPENIA; RETROSPECTIVE STUDY; SCHOOL CHILD; SEPSIS; SEPTIC SHOCK; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; BACTEREMIA; CASE-CONTROL STUDIES; CHILD; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEUTROPENIA; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 0141538187     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Diekema DJ, Pfaller MA, Schmitz FJ. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 2001;32 Suppl 2:S114-S32.
2. Steinberg JP, Clark CC, Hackman BO, Nosocomial and community-acquired staphylococcus aureus bacteremias from 1980 to 1993: impact of intravascular devices and methicillin resistance. Clin Infect Dis 1996;23:255-9.
3. Hospital Infections Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention. National Nosocomial Infections Surveillance (NNIS) report: data summary from October 1986 to April 1996. Am J Infect Control 1996;24:380-8.
4. Libman H, Arbeit RD. Complications associated with Staphylococcus aureus bacteremia. Arch Intern Med 1984;144:541-5.
5. Mylotte JM, McDermott C, Spooner JA. Prospective study of 114 consecutive episodes of Staphylococcus aureus bacteremia. Rev Infect Dis 1987;9:891-907.
6. Fowler VG Jr, Sanders LL, Sexton DJ, Kong L, Marr KA, Gopal AK, et al. Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients. Clin Infect Dis 1998; 27:478-86.
7. Lautenschlager S, Herzog C, Zimmerli W. Course and outcome of bacteremia due to Staphylococcus aureus: evaluation of different case definitions. Clin Infect Dis 1993;16:567-73.
8. Jensen AG, Wachmann CH, Espersen F, Scheibel J, Skinhoj P, Frimodt-Moller N. Treatment and outcome of Staphylococcus aureus bacteremia: a prospective study of 278 cases. Arch Intern Med 2002;165:25-32.
9. Falcone M, Carfagna P, Cassone M, Pistella E, Pavoni G, Nofroni I, et al. Staphylococcus aureus sepsis in hospitalized neutropenic patients: retrospective clinical and microbiological analysis. Ann Ital Med Int 2002;17:166-72.
10. Raad II, Sabbagh MF. Optimal duration of therapy for catheter-related Staphylococcus aureus bacteremia: a study of 55 cases and review. Clin Infect Dis 1992;14:75-82
11. Mylotte JM, Tayara A. Staphylococcus aureus bacteremia: predictors of 30-day mortality in a large cohort. Clin Infect Dis 2000;31:1170-4.
12. Roghmann MC. Predicting methicillin resistance and effect of inadequate empiric therapy on survival in patients with Staphylococcus aureus bacteremia. Arch Intern Med 2000;160:1001-4.
13. Gopal AK, Fowler VG Jr, Shah M, Gesty-Palmer D, Marr KA, McClelland RS, et al. Prospective analysis of Staphylococcus aureus bacteremia in nonneutropenic adults with malignancy. J Clin Oncol 2000;18:1110-5.
14. Sotman SB, Schimpff SC, Young VM. Staphylococcus aureus bacteremia in patients with acute leukemia. Am J Med 1980; 69:814-8.
15. Espersen F, Frimodt-Moller N, Rosdahl VT, Jessen O, Faber V, Rosendal K. Staphylococcus aureus bacteremia in patients with hematological malignancies and/or agranulocytosis. Acta Med Scand 1987;222:465-70.
16. Skov R, Gottschau A, Skinhoj P, Frimodt-Moller N, Rosdahl VT, Espersen F. Staphylococcus aureus bacteremia: a 14-year nation-wide study in hematological patients with malignant disease or agranulocytosis. Scand J Infect Dis 1995;27:563-8.
17. Gonzales-Barca E, Carratalà J, Mykietiuk A. Predisposing factors and outcome of Staphylococcus aureus bacteremia in neutropenic patients with cancer. Eur J Clin Microbiol Infect Dis 2001;20:1179.
18. The GIMEMA Infection Program. Prevention of bacterial infection in neutropenic patients with hematologic malignancies. Ann Intern Med 1991;115:7-12.
19. Martino P, Venditti M, Petti MC, Mandelli F, Serra P. Cotrimoxazole prophylaxis in patients with leukemia and prolonged granulocytopenia. Am J Med Sci 1984;287:7-9.
20. Venditti M, Martino P, Viscoli C, Klastersky J. Ceftriaxone alone or in combination with antibiotics in the management of infection in cancer patients. Clin Drug Invest 1999;17:195-210.
21. Martino P, Girmenia C, Raccah R, Micozzi A, Cimino G, Mandelli F. Ceftriaxone and amikacin as single daily dose in the empiric therapy for febrile episodes in neutropenic patients. Haematologica 1990;75:69-74.
22. Martino P, Girmenia C, Raccah R, Micozzi A, Cimino G, Sgadari C, et al. Single daily dose ceftriaxone plus amikacin treatment of febrile episodes in neutropenic patients attending day hospital for hematologic malignancies. Oncology 1992;49:49-52.
23. Martino P, Micozzi A, Gentile G, Raccah R, Girmenia C, Mandelli F. Piperacillin plus amikacin vs. piperacillin plus amikacin plus teicoplanin for empirical treatment of febrile episodes in neutropenic patients receiving quinolone prophylaxis. Clin Infect Dis 1992;15:290-4.
24. Micozzi A, Nucci M, Venditti M, Gentile G, Girmenia C, Meloni G, et al. Piperacillin/tazobactam/amikacin versus piperacillin/amikacin/teicoplanin in the empirical treatment of neutropenic patients. Eur J Clin Microbiol Infect Dis 1993;12:1-8.
25. Menichetti F, Martino P, Bucaneve G, Gentile G, D'Antonio D, Liso V, et al. Effects of teicoplanin and those of vancomycin in initial empirical antibiotic regimen for febrile, neutropenic patients with hematologic malignancies. GIMEMA Infection Program. Antimicrob Agents Chemother 1994;38:2041-6.
26. Dajani AS, Taubert KA, Wilson W, Bolger AF, Bayer A, Ferrieri P, et al. Prevention of bacterial endocarditis. Recommendations by the American Heart Association. JAMA 1997;277:1794-801.
27. Chow JW, Fine MJ, Shlaes M, Quinn JP, Hooper DC, Johnson MP, et al. Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med 1991;115:585-90.
28. Mc Cabe WR, Jackson GG. Gram negative bacteria. Etiology and ecology. Arch Intern Med 1962;110:847-55.
29. Muckart DJ, Bhagwanjee S. American College of Chest Physician/Society of Critical Care Medicine Consensus Conference: definitions of the systemic inflammatory response syndrome and allied disorders in relation to critically injured patients. Crit Care Med 1997;25:1789-95.
30. Bayer AS, Ward JI, Ginzton LE, Shapiro SM. Evaluation of new clinical criteria for the diagnosis of infective endocarditis. Am J Med 1994;96:211-9.
31. Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Am J Med 1994;96:200-9.
32. th ed. Washington, DC: ASM Press; 1995. p. 299-307.
33. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing; eight informational (Suppl) Approved standard, document M100-S8. Villanova, PA; NCCLS. 1999.
34. Viscoli C, Bruzzi P, Castagnola E, Boni L, Calandra T, Gaya H, et al. Factors associated with bacteremia in febrile, granulocytopenic cancer patients. The International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC). Eur J Cancer 1994;4:430-7.
35. European Organisation for Research and Treatment of Cancer (EORTC) International Antimicrobial Therapy Co-operative Group. Gram-positive bacteremia in granulocytopenic cancer patients. Eur J Cancer 1990;26:569-74.
36. Parrillo JE, Parker MM, Natanson C, Suffredini AF, Danner RL, Cunnion RE, et al. Septic shock in humans. Ann Intern Med 1990;113:227-42.
37. Bone RC. Pathophysiology of sepsis. Ann Intern Med 1991;457-69.
38. Henneke P, Golenbock DT. Innate immune recognition of lipopolysaccharide by endothelial cells. Crit Care Med 2002;30 5 Suppl:S207-13.
39. Munshi N, Fernandis AZ, Cherla RP, Park IW, Ganju RK. Lipopolysaccharide-induced apoptosis of endothelial cells and its inhibition by vascular endothelial growth factor. J Immunol 2002; 168:5860-6.
40. Danner RL, Elin RJ, Hosseini JM, Wesley RA, Reilly JM, Parillo JE. Endotoxemia in human septic shock. Chest 1991;99:169-75.
41. De Kimpe SJ, Kengatharan M, Thiemermann C, Vane JR. The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure. Proc Natl Acad Sci 1995;92:10359-63.
42. Yipp BG, Andonegui G, Howlett CJ, Robbins SM, Hartung T, Ho M, et al. Profound differences in leukocyte-endothelial cell response to lipopolysaccharide versus lipotheicoic acid. J Immunol 2002;168:4650-8.
43. Cross AS, Opal SM, Sadoff JC, Gemski P. Choice of bacteria in animal models of sepsis. Infect Immun 1993;61:2741-7.
44. Gresham HD, Lowrance JH, Caver TE, Wilson BS, Cheung AL, Lindberg FP, et al. Survival of Staphylococcus aureus inside neutrophils contributes to infection. J Immunol 2000;164:3713-22.
45. Daniel WG, Mugge A. Transesophageal echocardiography. N Engl J Med 1995;332:1268-79.
46. Fowler VG Jr, Sanders LL, Kong LK, McClelland RS, Gottlieb GS, Li J, et al. Infective endocarditis due to Staphylococcus aureus: 59 prospectively identified cases with follow-up. Clin Infect Dis 1999;28:106-14.
47. Rosen AB, Fowler VG Jr, Corey GR, Downs SM, Biddle AK, Li J, et al. Cost-effectiveness of transesophageal echocardiography to determine the duration of therapy for intravascular catheter-associated Staphylococcus aureus bacteremia. Ann Intern Med 1999;130:810-20.
48. Heidenreich PA, Masoudi FA, Maini B, Chou TM, Foster E, Schiller, et al. Echocardiography in patients with suspected endocarditis: a cost-effective analysis. Am J Med 1999;107:198-208.
49. Girmenia C, Moleti ML, Cartoni C, Cedrone M, De Gregoris C, De Sanctis V, et al. Management of infective complications in patients with advanced hematologic malignancies in home care. Leukemia 1997;11:1807-12.
50. Minotti V, Genitle G, Bucaneve G, Iori AP, Micozzi A, Cavicchi F, et al. Domiciliary treatment of febrile episodes in cancer patients: a prospective randomized trial comparing oral versus parenteral empirical antibiotic treatment. Support Care Cancer 1999;7:134-9.